Literature DB >> 2794561

Prominence of IgG4 antibodies in the human responses to Strongyloides stercoralis infection.

R M Genta1, J P Lillibridge.   

Abstract

The participation of the four subclasses of IgG in the humoral response to Strongyloides stercoralis was assessed by analyzing total and parasite-specific responses of each IgG subclass in 20 patients with uncomplicated strongyloidiasis and 21 immunocompromised patients with extraintestinal disease. The total component of each subclass was normal in most patients. IgG4 antibodies (measured by ELISA) were the most prominent parasite-specific response in both groups. Specific IgG2 and IgG4 responses were significantly more elevated in immunocompetent than in immunosuppressed patients. When the reactivity of each IgG subclass was analyzed by immunoblotting on SDS-PAGE-separated larval antigens, IgG4 recognized more antigens than did any other subclass. No parasite antigens were selectively recognized by either clinical group. Thus the continuous antigenic stimulation of chronic strongyloidiasis may result in an enhanced IgG4 subclass response. However, no presence or absence of humoral responses specific for filariform larval antigens was associated with the extraintestinal dissemination of the parasite.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794561     DOI: 10.1093/infdis/160.4.692

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Dysregulation of strongyloidiasis: a new hypothesis.

Authors:  R M Genta
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

Review 2.  Serodiagnosis of parasitic diseases.

Authors:  S E Maddison
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

3.  Evaluation of immunoglobulin G subclass antibodies against recombinant Fasciola gigantica cathepsin L1 in an enzyme-linked immunosorbent assay for serodiagnosis of human fasciolosis.

Authors:  Chaisiri Wongkham; Chairat Tantrawatpan; Pewpan M Intapan; Wanchai Maleewong; Sopit Wongkham; Kunio Nakashima
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

4.  Coinfection of Strongyloides stercoralis and Aspergillus found in bronchoalveolar lavage fluid from a patient with stubborn pulmonary symptoms.

Authors:  Jie Guo; Yi Sun; Yanru Man; Xiaochun Huang; Qin Qin; Daoyin Zhou; Anmei Deng
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

5.  Update on strongyloidiasis in the immunocompromised host.

Authors:  Luis A Marcos; Angélica Terashima; Marco Canales; Eduardo Gotuzzo
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

Review 6.  Human infection with Strongyloides stercoralis and other related Strongyloides species.

Authors:  Thomas B Nutman
Journal:  Parasitology       Date:  2016-05-16       Impact factor: 3.234

7.  Evaluation of human IgG class and subclass antibodies to a 24 kDa antigenic component of Gnathostoma spinigerum for the serodiagnosis of gnathostomiasis.

Authors:  Porntip Laummaunwai; Kittisak Sawanyawisuth; Pewpan M Intapan; Verajit Chotmongkol; Chaisiri Wongkham; Wanchai Maleewong
Journal:  Parasitol Res       Date:  2007-04-29       Impact factor: 2.289

8.  IgG1, IgG4, and IgE antibody responses in human strongyloidiasis by ELISA using Strongyloides ratti saline extract as heterologous antigen.

Authors:  Rosângela M Rodrigues; Maria C de Oliveira; Mônica C Sopelete; Deise A O Silva; Dulcinéa M B Campos; Ernesto A Taketomi; Julia M Costa-Cruz
Journal:  Parasitol Res       Date:  2007-07-04       Impact factor: 2.289

9.  A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection.

Authors:  Roshan Ramanathan; Peter D Burbelo; Sandra Groot; Michael J Iadarola; Franklin A Neva; Thomas B Nutman
Journal:  J Infect Dis       Date:  2008-08-01       Impact factor: 5.226

Review 10.  A fatal case of systemic strongyloidiasis and review of the literature.

Authors:  L H Hagelskjaer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.